This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.
Tri-complex inhibitors (TCIs) are molecular glues that bind to active GTP-bound RAS and recruit the intracellular chaperone cyclophilin A (CYPA) to generate a synthetic inhibitory complex that blocks ...
An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...
The Higher Education Commission has launched PhD Country Directory Online System for the benefit of PhD scholars. It was inaugurated by Minister for Federal Education and Professional Training Rana ...
Ras-el-hanout is used in couscous, rice, meat and vegetable dishes ...
Iran has issued an evacuation warning for Ras Al-Khaimah as tensions continue to rise on Day 22 of the US-Israel-Iran war. The IRGC has warned of imminent strikes "in the near future," triggering ...
Daraxonrasib is poised to become the new standard of care for previously treated metastatic pancreatic cancer after detailed results from a Phase III clinical trial were released at the American ...
Insight blogs Reflections on ILA Berlin 7 July 2026 The 2026 ILA Berlin trade show provided a convergence of autonomous systems, networked combat legacy architectures, AI and innovation. RAeS Head of ...